In this study, we designed and expressed the anticancer BR2 containing the PR-PPD peptide from P. pastoris to target growth factor signaling pathways that requires PPD-SH3 interactions in NSCLC. This evidence concerns the gene PGR and non-small cell lung carcinoma.